Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Ohio State University Comprehensive Cancer Center
West German Study Group
Seagen Inc.
Ain Shams University
Canadian Cancer Trials Group
Canadian Cancer Trials Group
Novartis
GBG Forschungs GmbH
University College, London
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hamamatsu University
Bristol-Myers Squibb